MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ:GILD)

152.50 +3.13 (+2.10%)
Official Closing Price Updated: 4:15 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,510,037
Open 149.69
Bid (Size) 151.60 (600)
Ask (Size) 152.50 (200)
Prev. Close 149.37
Today's Range 148.71 - 153.13
52wk Range 93.37 - 153.13
Shares Outstanding 1,253,809,440
Dividend Yield 2.07%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma
From Gilead Sciences, Inc.
Via Business Wire
News headline image
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 5 Years ↗
 
Via Benzinga

Performance

YTD
+25.4%
+25.4%
1 Month
+26.4%
+26.4%
3 Month
+29.1%
+29.1%
6 Month
+26.6%
+26.6%
1 Year
+58.8%
+58.8%

More News

Read More
News headline image
This Overlooked Biotech Giant Could Surprise Investors This Quarter
Via Barchart.com
News headline image
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Challenges
Via StockStory
Gilead Sciences Inc. (NASDAQ:GILD) Passes the Caviar Cruise Quality Investing Screen ↗
Via Chartmill
GILEAD SCIENCES INC (NASDAQ:GILD): A High-Yield, Low-Payout Dividend Stock for Disciplined Investors ↗
Via Chartmill
News headline image
Crossroads4Hope Kicks Off Its 25th Year of Caring with the Launch of Free Breast and Colorectal Cancer Resources for Patients and Families Nationwide
Via PRLog
News headline image
Large Cap Biopharmaceuticals: A Core Position For A Healthcare Portfolio ↗
Via Talk Markets
Topics Stocks
News headline image
3 Cash-Producing Stocks with Warning Signs
Via StockStory
News headline image
The Commonwealth Club Honors Black History Month With Event Featuring Top Black Leaders in AI & Biopharma Discussing the Future of Healthcare
Via Get News
Topics Artificial Intelligence
News headline image
Are Wall Street Analysts Predicting Gilead Sciences Stock Will Climb or Sink?
Via Barchart.com
Topics ETFs
News headline image
Gilead Sciences to Release Fourth Quarter & Full Year 2025 Financial Results on Tuesday, February 10, 2026
From Gilead Sciences, Inc.
Via Business Wire
News headline image
Demystifying Gilead Sciences: Insights From 17 Analyst Reviews ↗
Via Benzinga
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
Here's How Much $1000 Invested In Gilead Sciences 15 Years Ago Would Be Worth Today ↗
Via Benzinga
News headline image
New England Journal of Medicine Publishes Phase 3 ASCENT-04/KEYNOTE-D19 Results Supporting Trodelvy® Plus Keytruda® as a Potential New Standard of Care in First-line PD-L1+ Metastatic Triple-negative Breast Cancer
From Gilead Sciences, Inc.
Via Business Wire
News headline image
Gilead Sciences Earnings Preview: What to Expect
Via Barchart.com
Topics Artificial Intelligence ETFs Government
News headline image
Looking Into Gilead Sciences Inc's Recent Short Interest ↗
Via Benzinga
News headline image
A New Era in Rare Hepatology: The Deep-Dive Analysis of Mirum Pharmaceuticals (MIRM)
Via PredictStreet
Topics Economy Initial Public Offering
J&J Cuts Deal With Trump’s White House To Slash Drug Prices And Dodge Tariffs ↗
Via Stocktwits
Topics Government
News headline image
The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Gilead Sciences (GILD): Buy, Sell, or Hold Post Q3 Earnings?
Via StockStory
Topics Stocks
News headline image
U.S. Scales Back The Number Of Vaccines It Recommends For Every Child ↗
Via Stocktwits
Topics Government
News headline image
3 Cash-Flow Machines Investors May Want Heading Into 2026 ↗
Via MarketBeat
News headline image
Here's How Much $1000 Invested In Gilead Sciences 15 Years Ago Would Be Worth Today ↗
Via Benzinga

Frequently Asked Questions

Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 152.50
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 02/06/26 04:15 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 191.21B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 191B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story